Teachers Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
MP
MVP
DCM
Teachers Advisors's TCRT Position: Q1 2019 in Review
Teachers Advisors increased its Alaunos Therapeutics (TCRT) stake by 15% in Q1 2019, buying an estimated $138K and bringing the position to 2,474 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2136.
Teachers Advisors first reported a position in TCRT in Q2 2013 and has held it in 24 quarters since. The position peaked at $2M in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q1 2019.
- Teachers Advisors held 2,474 shares of Alaunos Therapeutics worth $1.43M as of Q1 2019.
- Teachers Advisors bought 330 Alaunos Therapeutics shares in Q1 2019, an estimated $138K.
- Alaunos Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2136 holding.
- Teachers Advisors first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 24 quarters since.
- Teachers Advisors's Alaunos Therapeutics position peaked at $2M in Q2 2015.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2019.
Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.